Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

被引:85
作者
Ding, Qunxing [1 ]
Dimayuga, Edgardo [1 ]
Keller, Jeffrey N. [1 ]
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging 205, Lexington, KY 40536 USA
关键词
Alzheimer's disease; lysosome; Mild Cognitive Impairment; oxidative stress; proteasome; protein synthesis; ribosome; RNA;
D O I
10.2174/156720507779939788
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A large number of studies has firmly established that increases in oxidative damage occurs in Alzheimer's disease (AD). Such studies have demonstrated that increased in oxidative damage selectively occurs within the brain regions involved in regulating cognitive performance. Studies from our laboratory and others have provided experimental evidence that increased levels of oxidative damage occur in subjects with Mild Cognitive Impairment (MCI), which is believed to be one of the earliest stages of AD, and is a condition which is devoid of dementia or the extensive neurofibrillary pathology and neuritic plaque deposition observed in AD. Together, these data support a role for the accrual of oxidative damage potentially serving as an earl), event that then initiates the development of cognitive disturbances and pathological features observed in AD. Recent studies from our laboratory have demonstrated that a decline in protein synthesis capabilities occurs in the same brain regions which exhibit increased levels of oxidative damage in MCI and AD subjects. The focus of this review is to describe the large number of studies which suggest protein synthesis may be one of the earliest cellular processes disrupted by oxidative damage in AD. Taken together, these findings have important implications for understanding the molecular and cellular basis of AD, understanding the basis for oxidative stress in AD, and may have important implications for studies involving protcomics and proteolysis in AD.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 60 条
[1]   Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease [J].
An, WL ;
Cowburn, RF ;
Li, L ;
Braak, H ;
Alafuzoff, I ;
Iqbal, K ;
Iqbal, IG ;
Winblad, B ;
Pei, JJ .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :591-607
[2]   Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins [J].
Butterfield, DA ;
Kanski, J .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (09) :945-962
[3]  
Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
[4]  
Charette M, 2000, IUBMB LIFE, V49, P341
[5]   Degradation of oxidized proteins by the 20S proteasome [J].
Davies, KJA .
BIOCHIMIE, 2001, 83 (3-4) :301-310
[6]   Protein quality control in Alzheimer's disease by the ubiquitin proteasome system [J].
de Vrij, FMS ;
Fischer, DF ;
van Leeuwen, FW ;
Hol, EM .
PROGRESS IN NEUROBIOLOGY, 2004, 74 (05) :249-270
[7]  
DICKSON DW, 1997, NEUROBIOL AGING, V18, P21
[8]  
Ding H, 2001, NEURO-ONCOLOGY, V3, P1, DOI 10.1093/neuonc/3.1.1
[9]   Ribosome dysfunction is an early event in Alzheimer's disease [J].
Ding, QX ;
Markesbery, WR ;
Chen, QH ;
Li, F ;
Keller, JN .
JOURNAL OF NEUROSCIENCE, 2005, 25 (40) :9171-9175
[10]   Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures [J].
Ding, QX ;
Dimayuga, E ;
Markesbery, WR ;
Keller, JN .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (05) :1211-1218